Full-Time

Senior AI Platform Engineer

Lirio

Lirio

51-200 employees

Behavioral-AI health engagement personalisation engine

Compensation Overview

$165k - $185k/yr

No H1B Sponsorship

Remote in USA

Remote

First-week onsite at a Tennessee office; travel expenses covered.

Category
DevOps & Infrastructure (1)
Required Skills
Kubernetes
Pinecone
Microsoft Azure
Python
Java
Docker
TypeScript
C#
Go
Terraform
LangChain
Databricks
Snowflake
Requirements
  • 3–5+ years of experience in healthcare technology, with a deep understanding of clinical workflows, Electronic Health Record integration (e.g., Epic, Cerner), and HL7/FHIR data standards
  • Proven track record of building cloud-native autonomous agent systems in regulated environments, including the implementation of safeguards for direct patient/member interaction
  • Extensive experience in LLMOps/MLOps, specifically managing the transition of agentic prototypes into production-grade healthcare applications
  • Hands-on experience with LLM APIs, AI coding tools (cursor, co-pilot, claude code, etc) and orchestration frameworks
  • Strong understanding of compliance requirements in regulated environments (HIPAA/HITRUST)
  • Ability to design, implement, and maintain complex automation and agent workflows
  • Experience with security, audit, and risk mitigation in software delivery
  • Programming Languages: Expert proficiency in Python (primary for AI) and C# or Java (for enterprise integration)
  • Azure AI Services: Hands-on experience with Azure OpenAI Service, Azure AI Agent Service, and Azure Machine Learning
  • Orchestration & Data Tools: Proficiency with LangChain, Microsoft Semantic Kernel, and Databricks and/or Snowflake
  • Interoperability Protocols: Deep hands-on experience with emerging agent communication standards, specifically the Model Context Protocol (MCP), including proficiency with its SDKs (Python, TypeScript, or Go)
  • Infrastructure & DevOps: Advanced skills in Terraform for Infrastructure as Code, Docker, Kubernetes (AKS), and Azure DevOps for CI/CD
  • Vector Databases: Experience with Pinecone, Weaviate, or Azure AI Search for high-dimensional data retrieval
  • Experience in healthcare, fintech or other regulated industries
  • Familiarity with multi-model AI routing and benchmarking
  • Demonstrated ability to lead platform adoption and drive organizational change
Responsibilities
  • Design and implement infrastructure to support LLM-based autonomous agents capable of multi-step reasoning, planning, and task execution
  • Build and manage directed workflows using state machines and tools to coordinate complex AI-human handoffs
  • Lead the architectural design and technical implementation of interoperability standards that enable seamless communication between autonomous agents and diverse software ecosystems
  • Architect and maintain cloud-native platforms that support end-to-end AI workflows, from model experimentation to high-availability production deployment
  • Develop evaluation frameworks and observability dashboards to monitor agent accuracy, latency, cost, and safety guardrails
  • Optimize agent performance by managing tool discovery and context window efficiency through standardized protocols, ensuring agents can dynamically access and execute the right capabilities on-the-fly
  • Embed healthcare regulatory compliance (e.g. HIPAA) directly into the platform layer through automated guardrails and audit trails
  • Implement security controls against prompt injection and ensure PII/PHI de-identification within agentic data flows
  • Implement secure authentication, role-based access controls, and data masking within interoperability layers to serve as a secure gatekeeper between AI agents and sensitive enterprise systems
  • Provide subject matter expertise and technical support to engineering teams during implementation
  • Build prototypes, reference integrations, or proof-of-concept solutions to validate design decisions and de-risk complex implementations
  • Evaluate existing systems and propose improvements or replacements
  • Promote AI-assisted engineering tools and modern development practices consistent with Lirio’s engineering culture
  • Document processes, designs, implementations, and best practices for future reference
  • Serve as a contributing member of Lirio’s Architecture Team, helping to maintain architectural coherence and platform quality
  • Partner with Product Management to shape solution approaches before work enters development planning and execution
  • Work closely with Cloud, Data, AI/ML, Behavioral Science, and Engineering teams to ensure solutions support personalization, scalability, and measurable outcomes
  • Participate in the Engineering Council, helping to define and uphold engineering standards, patterns, and technical governance
  • Diagnose and respond to issues in the implementation of agent orchestrations, adjusting guardrails and workflows as needed
Desired Qualifications
  • Prior work with Model Context Protocol (MCP) or similar integration standards
  • Familiarity with multi-model AI routing and benchmarking
  • Demonstrated ability to lead platform adoption and drive organizational change

Lirio uses behavioral science and AI to improve patient engagement and health outcomes. Its Precision Nudging personalisation engine analyzes individual behaviors, communication patterns, and social/clinical context to deliver hyper-personalized messages and interventions that encourage adherence and screenings. By moving beyond demographics, it enables real-time, one-to-one outreach to sustain engagement across care journeys, partnering with health systems, payers, and provider organizations. The goal is to reduce gaps in care and lower total cost of care by guiding patients through their evolving healthcare journey.

Company Size

51-200

Company Stage

N/A

Total Funding

$33.1M

Headquarters

Knoxville, Tennessee

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Launched Precision Nudging® for Life Sciences in 2024, targeting pharma patient journeys.
  • Cone Health partnership deploys AI for hypertension and diabetes adherence in 2024.
  • BrightInsight integration yields 60% lift in disengaged diabetes patient visits.

What critics are saying

  • BrightInsight commoditizes Precision Nudging, eroding standalone value in 6-12 months.
  • IQVIA crushes life sciences expansion with superior data in 12-24 months.
  • FDA AI guidelines halt unvalidated nudges, triggering client exodus in 12-18 months.

What makes Lirio unique

  • Precision Nudging® fuses behavioral science with AI for hyper-personalized health nudges.
  • Large Behavior Model processes biometrics, SDOH, and history for tailored interventions.
  • Behavioral Reinforcement Learning agents autonomously optimize nudges at individual scale.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Lirio who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

10 paid holidays + holiday week company closure

Unlimited Paid Time Off

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

5%

2 year growth

4%
Business Wire
Feb 5th, 2026
Life sciences firms struggle with patient engagement as 70% cite adherence challenges costing $100B annually

Lirio, a behavioural science and AI platform, has released research revealing that traditional personalisation approaches in life sciences fail to improve patient engagement. The survey of over 75 life sciences executives, conducted by Sage Growth Partners, found that more than 70% identified clinical trial engagement and medication adherence as persistent challenges. The report highlights that nearly 50% of patients don't take medications as prescribed, contributing to $100 billion in annual preventable healthcare costs and 125,000 avoidable deaths. Despite growing direct-to-consumer strategies, only half of organisations use digital health technologies for patient engagement, and fewer than 3% partner with specialised vendors. The findings come as new regulations reshape pharmaceutical advertising, prompting life sciences companies to rethink patient engagement strategies beyond traditional mass messaging approaches.

Teknovation.biz
May 5th, 2025
Lirio Releases Report Titled (Re)Defining Personalization

Lirio, the Knoxville-based pioneer in the union of behavioral science and artificial intelligence to deliver better health outcomes, has released new industry findings on the significant impact that advanced health... The post Lirio releases report titled (Re)defining Personalization appeared first on Teknovation.biz.

Securities and Exchange Commission
May 2nd, 2025
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Securities and Exchange Commission
May 2nd, 2025
SEC FORM D/A

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Silverwood Partners
Feb 8th, 2024
Healthcare Private Placement and M&A Transactions Review Week Ending Feb 4, 2024 | Silverwood Partners

Strategy | Financing Transactions Private Placement / Financing Transactions Cellanome: The company raised $150 million of Series B venture funding from Premji Invest (US) and undisclosed investors on January 29, 2024, putting the company’s pre-money valuation at $375 million. The company is a developer of a unique multi-omics platform designed to measure biology at an unprecedented […]